Literature DB >> 3244704

'Taming' of wild rats (Rattus rattus) by 5HT1A agonists buspirone and gepirone.

D C Blanchard1, R J Rodgers, C A Hendrie, K Hori.   

Abstract

A battery of tests designed to elicit reactions to a variety of nonpainful threat stimuli was used to study the effects of the 5HT1A agonists buspirone (5-20 mg/kg), and gepirone (5-20 mg/kg) on the defensive repertoire of wild Rattus rattus. These two compounds produced very similar patterns of results on the test battery, with gepirone generally more effective: Both compounds failed to interfere with either spontaneous motor activity or avoidance/flight to an approaching experimenter. However, both reduced defensive reactivity to proximal threat stimuli, increasing passive contacts with the experimenter in an inescapable situation and reducing "proximal" defensive reactions: jump/flinch reactions to dorsal contact, and, boxing, and biting to a number of threat stimuli. Defensive threat vocalizations and jump attacks were also reduced, but less consistently, as was the experimenter's rating of subject's defensiveness to being picked up. This pattern of results suggested specific "taming" effects of buspirone and, especially, gepirone on defensive reactions. In combination with findings indicating somewhat different (benzodiazepines) to very different (ethanol) profiles for other anxiolytics in the same test battery, these results suggest that the Defense Test Battery may be capable of providing behavioural differentiation among various classes of anxiolytics.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3244704     DOI: 10.1016/0091-3057(88)90345-0

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  9 in total

Review 1.  Conceptual foundations of the UCSD Statin Study: a randomized controlled trial assessing the impact of statins on cognition, behavior, and biochemistry.

Authors:  Beatrice Alexandra Golomb; Michael H Criqui; Halbert White; Joel E Dimsdale
Journal:  Arch Intern Med       Date:  2004-01-26

2.  Prevention of the analgesic consequences of social defeat in male mice by 5-HT1A anxiolytics, buspirone, gepirone and ipsapirone.

Authors:  R J Rodgers; J K Shepherd
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 3.  Behavioral and pharmacogenetics of aggressive behavior.

Authors:  Aki Takahashi; Isabel M Quadros; Rosa M M de Almeida; Klaus A Miczek
Journal:  Curr Top Behav Neurosci       Date:  2012

4.  Diazepam changes risk assessment in an anxiety/defense test battery.

Authors:  D C Blanchard; R J Blanchard; P Tom; R J Rodgers
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 5.  Brain serotonin receptors and transporters: initiation vs. termination of escalated aggression.

Authors:  Aki Takahashi; Isabel M Quadros; Rosa M M de Almeida; Klaus A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2010-09-03       Impact factor: 4.530

6.  Evidence for differential effects of 8-OH-DPAT on male and female rats in the Anxiety/Defense Test Battery.

Authors:  D C Blanchard; J K Shepherd; R J Rodgers; R J Blanchard
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

7.  Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol.

Authors:  J C Cole; R J Rodgers
Journal:  Psychopharmacology (Berl)       Date:  1994-03       Impact factor: 4.530

8.  Differential modulation of antipredator defensive behavior in Swiss-Webster mice following acute or chronic administration of imipramine and fluoxetine.

Authors:  G Griebel; D C Blanchard; R S Agnes; R J Blanchard
Journal:  Psychopharmacology (Berl)       Date:  1995-07       Impact factor: 4.530

9.  A Game-Theoretical Winner and Loser Model of Dominance Hierarchy Formation.

Authors:  Klodeta Kura; Mark Broom; Anne Kandler
Journal:  Bull Math Biol       Date:  2016-06-24       Impact factor: 1.758

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.